SCHEDULE: T. Rowe Price Discloses 5% Stake in Revvity Inc.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.0% of Revvity Inc.'s common stock as of June 30, 2026.

Summary

• T. Rowe Price Associates, Inc. has filed an amendment to its Schedule 13G, reporting its beneficial ownership of Revvity Inc. common stock.
• As of June 30, 2026, T. Rowe Price Associates, Inc. beneficially owned 5,526,874 shares of Revvity Inc. common stock.
• This ownership represents 5.0% of the class of securities.
• The filing indicates sole voting power for 5,508,363 shares and sole dispositive power for 5,526,874 shares.
• The filing is made under Rule 13d-1(b) and certifies that the securities were acquired in the ordinary course of business and not for the purpose of influencing control.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as neutral to slightly negative, as it primarily reports a change in beneficial ownership to just over 5%, indicating a significant but not controlling stake, without providing new operational or financial performance data.

Positives

• T. Rowe Price Associates, Inc., a significant institutional investor, has taken a notable stake in Revvity Inc., potentially signaling confidence in the company's future prospects.
• The filing confirms T. Rowe Price's sole voting and dispositive power over its holdings, indicating clear control over its investment decisions.

Negatives

• The filing does not provide any new operational or financial performance data for Revvity Inc., limiting insights into the company's current health.
• The disclosure of a 5.0% stake, while significant, does not indicate a controlling interest, and the filing does not elaborate on the strategic intent behind this ownership level.

Risks

• While T. Rowe Price certifies that the shares were not acquired to influence control, any significant shift in their holdings could impact Revvity Inc.'s stock price.
• The filing does not detail any specific risks associated with Revvity Inc.'s business operations or market position.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding Revvity Inc.'s future performance. It solely reports on T. Rowe Price Associates, Inc.'s ownership stake.

Management Comments

• T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.
• By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that institutional investor filings like this Schedule 13G are common and reflect active portfolio management. The acquisition of a 5.0% stake by a major asset manager like T. Rowe Price in a company like Revvity Inc. (which operates in the life sciences and diagnostics sector) can be interpreted as a signal of interest, though not necessarily a precursor to a takeover or significant strategic shift.

Stakeholder Impact

• Shareholders: The filing may lead to increased investor interest in Revvity Inc. due to the significant stake taken by a prominent institutional investor. However, the lack of operational updates means the immediate impact on share price is uncertain.
• Management: Revvity Inc. management will be aware of the increased scrutiny from a major shareholder and may consider their perspectives in strategic decision-making.

Next Steps

• T. Rowe Price Associates, Inc. will continue to hold and manage its investment in Revvity Inc. according to its investment strategies.
• Future amendments to this Schedule 13G will be filed if there are material changes in ownership.

Key Dates

Keywords

Revvity Inc., T. Rowe Price Associates, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Investment Management